NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered peptides from Inno Peptides? Mail in a sample (US only) and let us test it.

Test my supply
65%
Finnrick rating
#374 of 500 ranked vendors
59 of 79 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Inno Peptides has its clearest purity-focused support in GHK-Cu, Retatrutide and BPC-157, with recent records and enough repeat testing to show mostly recoveries after isolated dips. Tirzepatide is volatile, while MOTS-c and Tesamorelin carry the weakest signal from repeated purity/fill misses and some missing identity or batch detail.

methodology →
vendor intelligence report
Vendor Intelligence Report: Inno Peptides

Corporate records tie the brand to a Wuhan Yingnuo/Wuhan INNO office trail, but the natural-person controller remains unresolved. Domain records show the historic storefront re-registered and parked while a lookalike store and search-funnel pages exploit the Inno name.

36 pages8 risk factors assessed12 Nov 2026
read the report
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%13 Aug 2026: 67%27 Aug 2026: 67%4 Sep 2026: 67%16 Sep 2026: 68%16 Sep 2026: 67%16 Sep 2026: 66%17 Sep 2026: 66%18 Sep 2026: 66%18 Sep 2026: 66%21 Sep 2026: 66%23 Sep 2026: 66%25 Sep 2026: 66%25 Sep 2026: 65%25 Sep 2026: 66%25 Sep 2026: 66%25 Sep 2026: 65%5 Oct 2026: 65%6 Oct 2026: 66%6 Oct 2026: 66%8 Oct 2026: 65%8 Oct 2026: 65%12 Oct 2026: 66%13 Oct 2026: 65%13 Oct 2026: 66%13 Oct 2026: 66%13 Oct 2026: 66%13 Oct 2026: 66%20 Oct 2026: 66%20 Oct 2026: 67%20 Oct 2026: 67%21 Oct 2026: 66%23 Oct 2026: 67%2 Nov 2026: 66%2 Nov 2026: 67%2 Nov 2026: 66%5 Nov 2026: 67%6 Nov 2026: 66%6 Nov 2026: 67%6 Nov 2026: 66%6 Nov 2026: 65%17 Nov 2026: current 65%67%68%65%Aug 26Nov 26
Peptide testing

Ordered peptides from Inno Peptides? Mail in a sample (US only) and let us test it.

Test my supply
Inno Peptides test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
6 Nov 2026
Pass
GHK-Cu
lab nameView COA
6 Nov 2026
Fail
Tesamorelin
lab nameView COA
6 Nov 2026
Fail
Tirzepatide
lab nameView COA
6 Nov 2026
Fail
Tirzepatide
lab nameView COA
5 Nov 2026
Pass
Retatrutide
lab nameView COA
2 Nov 2026
Fail
MOTS-c
lab nameView COA
2 Nov 2026
Fail
MOTS-c
lab nameView COA
2 Nov 2026
Fail
Cagrilintide
lab nameView COA
23 Oct 2026
Pass
BPC-157
lab nameView COA
21 Oct 2026
Fail
Retatrutide
lab nameView COA
1-10 of 80

About Inno Peptides test results from Finnrick

Inno Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 7 peptides and 80 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Inno Peptides peptides in this dataset are BPC-157 (7 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 80 recent tests.

Corrections
No corrections.
Peptide testing

Ordered peptides from Inno Peptides? Mail in a sample (US only) and let us test it.

Test my supply